TrialRMD open2021

Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3.

Daniel Aletaha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.